Scott Cooper, MD
Gastroenterology · Missoula, MTNPI 1821275900
Payments from drug & device makers
What this record shows
18 manufacturers reported payments, led by Covidien LP at 52.6% of the total. Reporting peaked in 2019 at $1,647 and has fallen 97.4% since, to $42 in 2025.
Across 40 payments — averaging $69.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Covidien LP$1K
- Ambu Inc.$571
- AbbVie$245
- Apollo Endosurgery US Inc$145
- Boston Scientific$50
- Takeda Pharmaceuticals U.S.A., Inc.$44
- plus $266 from 12 others
Across 20 payments — averaging $3929.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$79K
What the payments were for
- Speaking & faculty fees$1,42451%
- Food & beverage$1,36049%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Covidien LP | 2 | $1,463 |
| Ambu Inc. | 4 | $571 |
| AbbVie(2 entities) | 14 | $245 |
| Apollo Endosurgery US Inc | 1 | $145 |
| Boston Scientific | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| Intercept Pharmaceuticals, Inc. | 2 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $28 |
| Braintree Laboratories, Inc. | 2 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Bristol Myers Squibb | 1 | $22 |
| Nestle Healthcare Nutrition Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Gilead | 1 | $17 |
| Vivus LLC | 1 | $17 |
| Sanofi | 1 | $16 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,784 in reported general payments places this provider in the 85th percentile of 34 gastroenterology providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZenpepLipase/Protease/Amylase | 25 | $85,234 |
| LinzessLinaclotide | 55 | $30,836 |
| TrulancePlecanatide | 22 | $13,232 |
| MovantikNaloxegol Oxalate | 19 | $7,798 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 84 | $5,151 |
| Dexlansoprazole DrDexlansoprazole | 25 | $4,251 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 145 | $3,588 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 13 | $1,993 |
| Pantoprazole Sodium | 135 | $1,805 |
| Budesonide DrBudesonide | 12 | $1,170 |
| Omeprazole | 93 | $1,071 |
| Gavilyte-NSodium Chloride/Nahco3/Kcl/Peg | 41 | $838 |
| Dicyclomine Hcl | 22 | $586 |
| Famotidine | 49 | $542 |
| Esomeprazole Magnesium | 24 | $353 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $245 | $30,83655 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $36 | $13,23222 claims |
| Braintree Laboratories, Inc.Sutab | $27 | $1,99313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 34 gastroenterology providers in Montana.
Other gastroenterology in Missoula
- Kevin KolendichMissoula$3K
- Eric StoneMissoula$2K
- Casey KolendichMissoula$2K
- Edwin LevineMissoula$1K
- Jeff WillisMissoula$745
- Daniel SelvigMissoula$267
- Andrew HermanBozeman$7K
- Waring TribleBozeman$5K
- Michael LindnerBozeman$4K
- Juergen MuellerKalispell$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.